Skip to Content

Harding Loevner International Eq Instl Z HLIZX

Medalist Rating as of | See Harding Loevner Investment Hub
  • NAV / 1-Day Return 27.24  /  −0.77 %
  • Total Assets 14.5 Bil
  • Adj. Expense Ratio
    0.730%
  • Expense Ratio 0.730%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Foreign Large Growth
  • Investment Style Large Blend
  • Min. Initial Investment 10.0 Mil
  • Status Open
  • TTM Yield 2.01%
  • Turnover 18%

USD | NAV as of Jul 16, 2024 | 1-Day Return as of Jul 16, 2024, 12:32 AM GMT+0

Morningstar’s Analysis HLIZX

Will HLIZX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Less compelling than before but still appealing.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Harding Loevner International Equity retains its Above Average People rating after alterations to its management team, but its Process rating drops to Above Average from High owing to reduced confidence in its approach.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HLIZX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 31.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Taiwan Semiconductor Manufacturing Co Ltd ADR

4.14 580.6 Mil
Technology

Samsung Electronics Co Ltd DR

3.74 523.9 Mil
Technology

Shell PLC

3.44 481.8 Mil
Energy

DBS Group Holdings Ltd

3.19 446.7 Mil
Financial Services

Manulife Financial Corp

3.19 446.7 Mil
Financial Services

Roche Holding AG

3.15 442.4 Mil
Healthcare

Allianz SE

2.79 391.3 Mil
Financial Services

Schneider Electric SE

2.76 387.4 Mil
Industrials

Haleon PLC

2.57 360.2 Mil
Healthcare

Chugai Pharmaceutical Co Ltd

2.50 350.4 Mil
Healthcare